NCT05238922 2026-02-10Study of INCB123667 in Subjects With Advanced Solid TumorsIncyte CorporationPhase 1 Recruiting604 enrolled
NCT03294694 2025-05-31Ribociclib + PDR001 in Breast Cancer and Ovarian CancerDana-Farber Cancer InstitutePhase 1 Terminated33 enrolled